WOOFGENIX
LIVE

Serial Number

98055736

Owner

Woofgenix Inc.

Attorney

Jeffrey Legault

First Use Date

May 25, 2023

Filing Date

Jun 23, 2023

Add to watchlist:

No watchlists yet
View on USPTO

WOOFGENIX Trademark

Serial Number: 98055736 • Registration: 7892812

WOOFGENIX is a trademark filed by Woofgenix Inc. on June 23, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Woofgenix Inc. (4 trademarks)

200 Biscayne Blvd Way, Unit 705
Miami, FL 33131

Entity Type: 03

Trademark Details

Filing Date

June 23, 2023

Registration Date

August 12, 2025

First Use Anywhere

May 25, 2023

First Use in Commerce

December 4, 2024

Published for Opposition

May 14, 2024

Goods & Services

Diagnostic and specimen collection kits for veterinary purposes comprised primarily of sterile cotton swabs and also including collection tubes, biohazard bag and prepaid return mailer; diagnostic preparations for veterinary genetic and epigenetic and other biological testing, diagnosis and analysis; medical diagnostic reagents and assays for the testing and analysis of veterinary biological samples; food supplement or pharmaceutical preparations for veterinary use for anti-aging treatments and therapies, chronic disease management, cancer treatment and management, palliative care and pain management, life stage care, and personalized breed care

Veterinary services providing medical and diagnostic, analysis, monitoring and reporting services for treatment purposes for animals, in particular through genetic and epigenetic testing and other laboratory testing and analysis; consulting services in the fields of diagnostic veterinary testing, and animal health and nutrition; information, advisory and consultancy services relating to all the aforesaid services

Veterinary laboratory services; genetic, epigenetic and other diagnostic testing, analysis and reporting for scientific research purposes; custom design and development of assays for biochemical, biological, genetic and epigenetic testing and analysis; research and development and consulting services in the pharmaceutical research and development and biotechnology fields

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 12, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 12, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 20, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 20, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 11, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 10, 2025 AITU
USE AMENDMENT FILED
Jan 6, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 6, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 9, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 14, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 14, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 24, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 5, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 5, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 5, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 5, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 5, 2024 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 11, 2024 GNRN
NON-FINAL ACTION E-MAILED
Mar 11, 2024 GNRT
NON-FINAL ACTION WRITTEN
Mar 11, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 11, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 25, 2023 NWOS
NEW APPLICATION ENTERED
Jun 27, 2023 NWAP